Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
BioCardia financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$2.4
2024-10-29
Market Capitalization
$8.5 M
2024-10-29
Revenue
$58 K
FY, 2024
CreditSafe Score
?
Score changed on Jun 05, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 479.0K | 625.0K | 710.0K | 145.0K | 1.0M | 1.4M | 477.0K | 58.0K | |
| Revenue growth, % | 30.5% | ||||||||
| Cost of goods sold | 690.0K | 517.0K | 358.0K | 4.0K | |||||
| Gross profit | (211.0K) | 108.0K | 352.0K | 141.0K | |||||
| Gross profit margin, % | -44.1% | 17.3% | 49.6% | 97.2% | |||||
| General and administrative expense | 6.4M | 5.8M | 6.0M | 5.9M | 5.1M | 4.4M | 4.4M | 3.7M | 3.3M |
| Operating expense total | 12.2M | 14.2M | 14.6M | 15.7M | 13.6M | 13.3M | 12.1M | 8.1M | 8.3M |
| Depreciation and amortization | 24.0K | ||||||||
| EBIT | (12.4M) | (14.1M) | (14.2M) | (15.5M) | (12.6M) | (11.9M) | (11.6M) | (8.0M) | (8.3M) |
| EBIT margin, % | -2589.8% | -2256.3% | -2001.8% | -10709.7% | -880.3% | -2441.1% | -13794.8% | ||
| Interest income | 9.0K | ||||||||
| Net Income | (12.3M) | (14.0M) | (14.7M) | (15.0M) | (12.6M) | (11.9M) | (11.6M) | (7.9M) | (8.2M) |